DaVita Accelerates Commitment to Community Health with Nationwide Tour
DaVita (NYSE: DVA), a leading kidney care provider, has announced its 2024 nationwide community health tour starting September 24. The DaVita Health Tour offers free health screenings and chronic disease education across the country. This year's tour features an enhanced experience in collaboration with the American Diabetes Association (ADA), focusing on diabetes and chronic kidney disease (CKD) education, especially for underserved populations.
The tour will provide free screenings in California, Florida, Georgia, Pennsylvania, and Texas, regions with higher kidney disease prevalence. Screenings include glucose tests, blood pressure readings, BMI calculations, and optional blood draws for detailed kidney function assessment. This initiative aims to identify potential risk factors for CKD, diabetes, and hypertension early, allowing for timely intervention.
DaVita (NYSE: DVA), un importante fornitore di cure renali, ha annunciato il suo tour nazionale di salute comunitaria per il 2024 che inizierà il 24 settembre. Il DaVita Health Tour offre screening gratuiti per la salute e educazione sulle malattie croniche in tutto il paese. Il tour di quest'anno presenta un'esperienza potenziata in collaborazione con l'American Diabetes Association (ADA), concentrandosi sull'educazione riguardo il diabete e la malattia renale cronica (CKD), in particolare per le popolazioni svantaggiate.
Il tour fornirà screening gratuiti in California, Florida, Georgia, Pennsylvania e Texas, regioni con una maggiore prevalenza di malattie renali. Gli screening comprendono test della glicemia, misurazioni della pressione sanguigna, calcoli dell'IMC e prelievi di sangue opzionali per una valutazione dettagliata della funzione renale. Questa iniziativa mira a identificare precocemente i potenziali fattori di rischio per CKD, diabete e ipertensione, consentendo interventi tempestivi.
DaVita (NYSE: DVA), un proveedor líder en cuidado renal, ha anunciado su gira nacional de salud comunitaria para 2024 que comenzará el 24 de septiembre. La DaVita Health Tour ofrece exámenes de salud gratuitos y educación sobre enfermedades crónicas en todo el país. La gira de este año cuenta con una experiencia mejorada en colaboración con la American Diabetes Association (ADA), centrándose en la educación sobre la diabetes y la enfermedad renal crónica (CKD), especialmente para las poblaciones desfavorecidas.
La gira proporcionará exámenes gratuitos en California, Florida, Georgia, Pennsylvania y Texas, regiones con mayor prevalencia de enfermedades renales. Los exámenes incluyen pruebas de glucosa, mediciones de presión arterial, cálculos de IMC y extracciones de sangre opcionales para una evaluación detallada de la función renal. Esta iniciativa tiene como objetivo identificar factores de riesgo potenciales para CKD, diabetes e hipertensión de manera temprana, lo que permite una intervención oportuna.
DaVita (NYSE: DVA)는 9월 24일부터 시작되는 2024년 전국 커뮤니티 건강 투어를 발표했습니다. DaVita Health Tour는 전역에서 무료 건강 검진과 만성 질환 교육을 제공합니다. 올해의 투어는 미국 당뇨병 협회(ADA)와의 협력을 통해 개선된 경험을 특징으로 하며, 특히 취약 계층을 대상으로 당뇨병 및 만성 신장 질환(CKD) 교육에 중점을 두고 있습니다.
이 투어는 캘리포니아, 플로리다, 조지아, 펜실베이니아 및 텍사스에서 무료 검진을 제공하며, 이 지역은 신장 질환 유병률이 높습니다. 검진 항목에는 혈당 검사, 혈압 측정, BMI 계산 및 자세한 신장 기능 평가를 위한 선택적 혈액 채취가 포함됩니다. 이 이니셔티브는 CKD, 당뇨병 및 고혈압의 잠재적 위험 요소를 조기에 발견하여 적시에 개입할 수 있도록 하는 것을 목표로 합니다.
DaVita (NYSE: DVA), un fournisseur de soins rénaux de premier plan, a annoncé sa tournée nationale de santé communautaire pour 2024, qui débutera le 24 septembre. La DaVita Health Tour propose des dépistages de santé gratuits et une éducation sur les maladies chroniques à travers le pays. La tournée de cette année présente une expérience améliorée en collaboration avec l'American Diabetes Association (ADA), axée sur l'éducation au sujet du diabète et de la maladie rénale chronique (CKD), en particulier pour les populations défavorisées.
La tournée proposera des dépistages gratuits en Californie, Floride, Géorgie, Pennsylvanie et Texas, des régions où la prévalence des maladies rénales est plus élevée. Les dépistages incluent des tests de glucose, des mesures de la pression artérielle, des calculs d'IMC et des prises de sang facultatives pour une évaluation détaillée de la fonction rénale. Cette initiative vise à identifier tôt les facteurs de risque potentiels de CKD, de diabète et d'hypertension, permettant ainsi une intervention rapide.
DaVita (NYSE: DVA), ein führender Anbieter von Nierengesundheitsdienstleistungen, hat seine landesweite Gesundheitstour für 2024 angekündigt, die am 24. September beginnt. Die DaVita Health Tour bietet kostenlose Gesundheitsuntersuchungen und Aufklärung über chronische Krankheiten im ganzen Land an. In diesem Jahr bietet die Tour ein verbessertes Erlebnis in Zusammenarbeit mit der American Diabetes Association (ADA), mit dem Fokus auf die Aufklärung über Diabetes und chronische Nierenerkrankungen (CKD), insbesondere für benachteiligte Bevölkerungsgruppen.
Die Tour wird kostenlose Untersuchungen in Kalifornien, Florida, Georgia, Pennsylvania und Texas anbieten, Regionen mit höherer Prävalenz von Nierenerkrankungen. Die Untersuchungen umfassen Glukosetests, Blutdruckmessungen, BMI-Berechnungen und optionale Blutentnahmen zur detaillierten Beurteilung der Nierenfunktion. Diese Initiative zielt darauf ab, potenzielle Risikofaktoren für CKD, Diabetes und Bluthochdruck frühzeitig zu identifizieren, um rechtzeitige Interventionen zu ermöglichen.
- Expansion of free health screening program to multiple states
- Collaboration with American Diabetes Association to enhance diabetes and CKD education
- Proactive approach to chronic disease prevention and early detection
- Targeting regions with higher prevalence of kidney disease for maximum impact
- None.
Kidney care leader provides free health screenings and resources to create awareness around kidney disease and open discussion around health care access
The 2024 tour will feature an enhanced experience in collaboration with the American Diabetes Association (ADA). DaVita and the ADA have established a multi-year collaboration focused on strengthening diabetes and chronic kidney disease (CKD) education, awareness and support, especially for underserved populations. The organizations will join forces to offer mobile pop-up screenings in select markets, providing more opportunities to reach communities in greater need.
"Health care providers are often playing defense when it comes to caring for some of the most vulnerable members of our communities. We're actively working to put them on offense through proactive patient engagement, education and resources that help address chronic disease preventatively," said Dr. Jeff Giullian, chief medical officer at DaVita. "The DaVita Health Tour is one of many ways we're supporting prevention and access to care with a community-driven focus—at both the national and local levels."
Free screenings will be available in communities across
"Connecting with people at stops throughout the tour has thrown into sharp focus the very real need to create and help ensure access to health care as a human right," Dr. Giullian said. "This tour is illustrative of our broader commitment to engaging with people who don't have access to care or don't know where to find resources."
The free health screenings available at each tour stop are designed to help individuals identify potential risk factors for CKD, diabetes and hypertension so they can work with their care provider to plan appropriate intervention as needed. Each screening includes:
- A glucose test via fingerstick to understand diabetes risk
- A blood pressure reading for hypertension awareness
- Measurements to calculate body mass index (BMI) and assess obesity risk
- An optional blood draw to offer more detailed measurement of kidney function
- A personal and confidential patient results review
To see where the DaVita Health Tour is heading and sign up for a free health screening, visit: DaVita.com/HealthTour.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of June 30, 2024, DaVita served approximately 265,100 patients at 3,124 outpatient dialysis centers, of which 2,672 centers were located in
Media Contact:
DaVita Newsroom
newsroom@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-accelerates-commitment-to-community-health-with-nationwide-tour-302250103.html
SOURCE DaVita
FAQ
When does DaVita's 2024 nationwide community health tour begin?
What services does DaVita (DVA) offer during its Health Tour?
Which states will DaVita's 2024 Health Tour visit?
Who is DaVita (DVA) collaborating with for the 2024 Health Tour?
